Save time and get answers to complex questions with AI chat
Campath litigation germany?Bivalirudin manufacturer?Dabrafenib and trametinib price?Patent tenofovir alafenamide gilead?Patent expiration date of guselkumab?
See the DrugPatentWatch profile for Latisse
Latisse’s active ingredient is bimatoprost. [1]
Yes. Latisse = bimatoprost ophthalmic solution 0.03%. [1]
Latisse is a branded version of bimatoprost used to treat hypotrichosis (eyelash thinning). Any “generic Latisse” would refer to bimatoprost products, not a different drug name. [1]
You’ll typically see it described by the ingredient bimatoprost and the concentration (0.03%), rather than “Latisse.” [1] Sources: [1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021281
Other Questions About Latisse :